Gilead drug prevents type of coronavirus in monkeys; raises hope for China trials squib

February 14, 2020 6:43 AM

CHICAGO (REUTERS) - An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East Respiratory Syndrome (Mers), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday (Feb 13) found.
Scroll for more
Continue reading on The Straits Times...